Reducing Arterial Stiffness with a Smart Ring and AI-Guided Exercise
GONDOR-AS
Guidance with Oura and AI for Reducing Arterial Stiffness - the GONDOR-AS Trial
1 other identifier
interventional
165
1 country
1
Brief Summary
The goal of this three-month clinical trial is to study if wearing an Oura Ring and following the exercise guidance provided by an AI-based Advisor in the Oura App works to reduce arterial stiffness. It will also study the difference between different exercise protocols in reducing arterial stiffness and improving aerobic fitness. The main questions the study aims to answer are:
- Can an AI-based Advisor provide useful exercise guidance that helps improve cardiovascular health and aerobic fitness?
- Does regular exercise lower arterial stiffness measured with a clinical reference device and Oura Ring's proprietary Cardiovascular Age -metric and its estimated arterial stiffness?
- Is there a difference between attending supervised high-intensity interval (HIIT) training sessions and following personalized exercise instructions for steady-state aerobic training? Participants will:
- Follow Oura's AI Advisor's instructions at their own convenience, attend supervised training sessions, or just wear the Ring without changing their lifestyle
- Visit an exercise physiology lab in the beginning of the trial and after three months for measurements in arterial stiffness, cardiorespiratory fitness, and body composition In addition, the study contains questionnaires investigating the participants' experiences related to lifestyle changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2024
CompletedFirst Submitted
Initial submission to the registry
October 11, 2024
CompletedFirst Posted
Study publicly available on registry
October 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedDecember 3, 2024
November 1, 2024
11 months
October 11, 2024
November 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Arterial stiffness, clinical reference
Measurement of carotid-femoral pulse-wave velocity (PWV) using the Complior device (Alam Medical)
Three months
VO2max
Maximal oxygen consumption measured while cycling with an ergometer (Ergoselect 4, Ergoline GmbH, Germany), and VO2max will be measured by the breath-by-breath method (Vyntus CPX, Vyaire Medical, USA)
Three months
Secondary Outcomes (2)
Estimated PWV
Three months
Change in Cardiovascular Age
Three months
Other Outcomes (3)
Change in body weight
Three months
Change in body fat
Three months
Change in muscle mass
Three months
Study Arms (3)
AI-instructed group
EXPERIMENTALParticipants in this group will receive Oura Rings and access to AI-based exercise guidance. They are instructed to follow received instructions, but they are blinded to their outcome measure (CVA).
Supervised exercise group
ACTIVE COMPARATORParticipants in this group receive Oura Rings and are instructed to attend supervised HIIT-cycling sessions twice a week. They are blinded to their outcome measure (CVA).
Ring-only group
OTHERParticipants in this group receive Oura Rings but no AI-advice or supervised training. They are blinded to the outcome measure (CVA).
Interventions
Participant will communicate with a "chatbot-like" proprietary AI to receive exercise instructions. The AI will provide personalized advice according to the user's needs, aiming for 2-3 hours of steady-state zone 2 -effort aerobic exercise. Instructions will also be tailored to the user's exercise preferences and limitations (for example, suggest cycling, if running is not convenient).
Participants will only receive an Oura Ring, but will not change anything about their normal physical activity.
Eligibility Criteria
You may qualify if:
- Self-reported moderate intensity physical activity less than 2 hours 30 minutes per week or vigorous intensity physical activity less than 1 hour 15 minutes per week.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pauli Ohukainenlead
- Kuopio Research Institute of Exercise Medicinecollaborator
Study Sites (1)
Kuopio Institute of Exercise Medicine
Kuopio, Northern Savonia, 70210, Finland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Note: Participants are blinded to the outcome measure (CVA) on their Oura App. Outcomes are analyzed by blinded researchers not actively involved in data collection.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Research Scientist
Study Record Dates
First Submitted
October 11, 2024
First Posted
October 16, 2024
Study Start
September 16, 2024
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
December 3, 2024
Record last verified: 2024-11